BSD Medical Corporation | Return to Homepage
Home    |    Contact us    |    Terms of Use    |    Privacy Statement    |    Site Map        
BSD Medical -- Delivering Thermal Energy to Medicine
About BSD Medical Products For Patients For Healthcare Professionals Investor Relations

Press Releases

  • 10/15/14 7:15 am MDT

    Signs Distribution Agreement with KOL Bio-Medical Instruments, Inc.

    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that the company has signed an agreement with KOL Bio-Medical Instruments, Inc. (KOL) for the sales and distribution of BSD’s MicroThermX® Microwave Ablation (MicroThermX) line of products. KOL sales and distribution area will include up to 15 states in the Northeast, Mid-more...
  • 9/29/14 7:15 am MDT

    Creates Sales Pathway for BSD-2000 in Largest and Most Receptive Hyperthermia End-Market in the World

    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that BSD’s exclusive distributor in the People’s Republic of China, Dalian Orientech Co. LTD (“Orientech”), has informed BSD that China’s Food and Drug Administration (the “CFDA”) has approved and renewed the marketing and import license application for the BSD-2000more...
  • 9/25/14 7:15 am MDT

    German Joint Health Insurance Funds Reimburse Quality Controlled Pediatric Hyperthermia Treatments of Solid Tumors

    This is the Second German Center Established for the Treatment of Pediatric Tumors

    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that the Charité Universitätsmedizin Berlin (Charité), Department of Pediatric Hematology and Oncology, in cooperation with the Charité Department of Radiation Oncology, has opened a center dedicated to the treatment of pediatric tumors using hyperthermia and chemotherapy. Prof. Angelika Eggert MD, Chair of the Department of Pediatric Hematology and Oncology as wellmore...
  • 9/22/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) announced today that Terumo Europe NV (Terumo), a wholly owned subsidy of Terumo Corporation, successfully showcased BSD’s MicroThermX® Microwave Ablation System (MicroThermX) at the annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) conference, the world’s largest and most prestigious conference in the field of minimally invasive image-guided therapies. Terumomore...
  • 9/3/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that BSD has completed the sale of its fourth BSD-2000 Hyperthermia Systems (BSD-2000) ordered by its exclusive Taiwan distributor, Linden Bioscience Co., Ltd (Linden). Linden is a leading distributor of sophisticated medical devices in Taiwan. The Company hasmore...
  • 8/27/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today announced it will be featured as a presenting company at the 16th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The investor conference is being held September 8-10, 2014 at The Palace Hotel in New York Citymore...
  • 8/13/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that on August 8, 2014, it received a letter from the NASDAQ OMX GROUP (“Nasdaq”) stating that the bid price of the Company’s common stock for the last 30 consecutive trading days had closed below the minimum $1.00 per share required for continued listing under Listing Rule 5550(a)(2). The Nasdaq notification letter does not result in the immediatemore...
  • 8/7/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today announced that Luis Lopes has joined BSD Medical to support Terumo Europe NV’s (Terumo) sales and marketing team. Mr. Lopes will provide technical, educational and field support for BSD’s MicroThermX® Microwave Ablation System during Terumo’s continued, strategicmore...
  • 7/31/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that the Company has shipped a BSD-2000 Hyperthermia System (BSD-2000) to the prestigious University of California San Francisco Medical Center (UCSF Medical Center). UCSF Medical Center is one of the nation's top 10 hospitals and is recognized throughout the world for innovative patient care and advanced technology (http://www.ucsfhealth.org/about/). UCSF Medicalmore...
  • 7/23/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com) today announced that it has hired Shella Leahy to provide technical, clinical, educational and field support for its MicroThermX microwave ablation system in the United States. Ms. Leahy will lead educational and training activities with customers and sales representatives throughout the United States. “We continue to make solid inroads in the education,more...


Business Wire InvestorHQ℠